
    
      Benfotiamine pretreatment (3 days)at high dosage (1050 mg/day) prevents in healthy subjects
      smoking-induced vascular dysfunction assessed by ultrasound flow mediated dilatation (FMD) of
      the brachial arteryand laboratory parameters (adhesion molecules).
    
  